BILQUEES BEIG: Open Payments
NPI 1649719600 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 69 payments from 12 companies in 2025. Trend: 2023 $1,010 · 2024 $776 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $501 |
| Neurocrine BioSciences, Inc. | 12 | $192 |
| Vanda Pharmaceuticals Inc. | 8 | $163 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Alkermes, Inc. | 3 | $67 |
| Braeburn Inc. | 2 | $44 |
| Lundbeck LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, INGREZZA, FANAPT, COBENFY, ARISTADA, BRIXADI, REXULTI, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
